Analyzing Viral Severe Acute Respiratory Infections in Critically Ill Patients with Immunocompromised Conditions: Phenotypic Characteristics, Co-Infections, and Severity Levels
By
Djamel Mokart
Frédéric Gonzalez
Laurent Chow-Chine
Magali Bisbal
September 28, 2026
Clinical Scorecard: Analyzing Viral Severe Acute Respiratory Infections in Critically Ill Patients with Immunocompromised Conditions: Phenotypic Characteristics, Co-Infections, and Severity Levels
At a Glance
Category Detail
Condition Viral Severe Acute Respiratory Infections (SARI) Key Mechanisms Immunocompromised status affecting various immune functions and increasing infection risk. Target Population Critically ill patients with immunocompromised conditions in ICUs. Care Setting Intensive Care Units (ICUs)
Key Highlights
Immunocompromised status linked to increased in-hospital mortality. Diverse immune profiles among immunocompromised patients affect infection risk. Co-infections with bacteria, fungi, and parasites complicate viral SARI cases. Viral infection's prognostic value is context-dependent. Treatment limitations may influence mortality outcomes. Guideline-Based Recommendations
Diagnosis
Consider a syndromic framework for defining immunocompromised status. Management
Assess co-infections and immune profiles in critically ill patients. Monitoring & Follow-up
Monitor for polymicrobial infections in patients with viral SARI. Risks
Increased mortality risk associated with neutropenia and poor performance status. Patient & Prescribing Data
Critically ill patients with various immunocompromised conditions.
Treatment decisions may differ based on immunocompromised status and severity.
Clinical Best Practices
Utilize APACHE or SOFA scores for assessing severity in immunocompromised patients. Incorporate assessment of treatment limitations in mortality analyses. Related Resources & Content
